MicroRNAs in Atrial Fibrillation.
atrial fibrillation
biomarkers
cardiovascular disease
miRNAs
remodelling
small non-coding RNA.
Journal
Current medicinal chemistry
ISSN: 1875-533X
Titre abrégé: Curr Med Chem
Pays: United Arab Emirates
ID NLM: 9440157
Informations de publication
Date de publication:
2019
2019
Historique:
received:
10
10
2016
revised:
20
11
2016
accepted:
29
11
2016
pubmed:
22
9
2017
medline:
18
5
2019
entrez:
22
9
2017
Statut:
ppublish
Résumé
MicroRNAs (miRNAs) are small non-coding RNAs, involved in regulation of post-transcriptional gene expression. They exert key role not only in physiology and normal development of the cardiovascular system but also in cardiovascular disease development and progression. Recent animal and human studies of tissue specific miRNAs have suggested a role in structural and electrical remodeling in atrial fibrillation (AF). Their emerging role as biomarkers and potential therapeutic targets in patients with AF is discussed in this review.
Identifiants
pubmed: 28933293
pii: CMC-EPUB-85906
doi: 10.2174/0929867324666170920151024
doi:
Substances chimiques
Biomarkers
0
MicroRNAs
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
855-863Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.